ARWR vs PCRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jun 27, 2026

ARWR

60.2
AI Score
VS
ARWR Wins

PCRX

57.6
AI Score

Investment Advisor Scores

ARWR

60score
Recommendation
BUY

PCRX

58score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ARWR PCRX Winner
Forward P/E 111.1111 8.3056 PCRX
PEG Ratio -1.32 11.2121 Tie
Revenue Growth -86.4% 5.0% PCRX
Earnings Growth 9.8% -30.0% ARWR
Tradestie Score 60.2/100 57.6/100 ARWR
Profit Margin -48.4% 0.7% PCRX
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD ARWR

Frequently Asked Questions

Based on our detailed analysis, ARWR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.